Contrast-Enhanced MRI: Optimizing Imaging of the Brain and Spine

Viewing Information

Getting Started

To fully participate in this online program you must be registered and logged in. Read all the information presented below. When ready select the "View Program" tab above.

Claiming CE Credits

To receive CE credits, participants must review the program materials in their entirety and complete the online post examination and evaluation.

System Hardware/Software and Internet Connection Requirements

The following information is provided for your reference in conjunction with review of this program.

General System and Internet Requirements:  Speakers or Headphones, High Speed Internet connection, Wireless 3G and 4G,
Web browsers: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher and Chrome.

Operating Systems:  Windows 2000 or higher, (MS Surface and other MS mobile devices compatible), MAC OSX 10.3 or higher, Mac iOS 5.0 or higher (iPad, iPhone compatible), Android 4.3 or higher (most Android mobile devices compatible).

Program Summary

In this Expert Forum, Lawrence Tanenbaum, MD, FACR and Suzie Bash, MD review considerations for optimizing contrast-enhanced MRI in neuroimaging, extending from patient tolerance to standardizing procedures. Following the presentation questions from the audience were addressed in a moderated Q&A session.

CE Effective Date: November 24, 2021
CE Expiration Date: November 30, 2023

Format: Self Instructional - Audio Visual with Slides
Educational Credits:
One (1) ARRT Category A CE Credit
One (1) AHRA CRA Credit
Estimated Completion Time: 1 hour

This program is supported through an educational granti from GE Healthcare.

Target Audience & Cost

This program is intended for: Radiologic Technologists, Radiology Administrators and related Imaging Professionals.

There is no cost to participate in this program.

Educational Objectives

  1. Manage issues related to patient tolerability and acute adverse events.
  2. Implement standardized and optimized MR contrast-enhanced protocols.
  3. Identify clinical indications for contrast-enhanced MRI for brain and spine imaging

Presented by

Lawrence N. Tanenbaum, MD, FACR Lawrence N. Tanenbaum, MD, FACR
Vice President and Chief Technology Officer
Medical Director, Eastern Region
Director of Computed Tomography, MRI and Advanced Imaging
RadNet Inc. New York, NY

Dr. Tanenbaum is currently the Vice President & Chief Technology Officer, and Medical Director for the Eastern Region at RadNet, Inc., a leading provider of freestanding, fixed-site diagnostic imaging services in the United States. Prior to this role, Dr. Tanenbaum served as Associate Professor of Radiology and Director of MRI/CT & Outpatient / Advanced Imaging Development at the Icahn School of Medicine at Mount Sinai in New York.

Dr. Tanenbaum has authored approximately 100 scholarly and peer reviewed articles, continues to chair educational and academic meetings and has delivered over 1500 invited lectures around the world.

Suzie Bash, MD Suzie Bash, MD
Medical Director of Neuroradiology
San Fernando Valley Interventional Radiology
RadNet Inc.

Dr. Bash is the Medical Director of Neuroradiology at San Fernando Valley Interventional Radiology at RADNET. Dr. Bash joined RADNET in 2005. Prior to this she was on the faculty at UCLA as an Assistant Professor of Neuroradiology, after completing a 2-year Neuroradiology Fellowship at UCLA and Radiology Residency also at UCLA.

During her tenure at UCLA, Dr. Bash was the recipient of the Issa Yaghmai Scholarship for best paper published in a peer-reviewed journal; Consultant of the Year Award, issued by the Emergency Department to one UCLA resident a year; as well as the Outstanding Resident Award, issued by Olive View-UCLA to one resident a year. Dr. Bash was awarded James Scholar Honors during her medical school years at University of Illinois.

Dr. Bash’s passion and interests lie in Artificial Intelligence applications in Neuroimaging and other advanced Neuroimaging techniques which add patient-centric value and quality. She is actively involved in AI clinical trials and serves on the medical advisory boards to some outstanding AI companies.

Disclosures

Lawrence N. Tanenbaum, MD, FACR, discloses the following relationships:
Speaker: GE, Siemens, Philips, Hitachi, Canon
Consultant: Enlitic, Aidoc, Icometrix, IMedis,Columbo, Bracco, Fuji, Subtle

Suzie Bash, MD, discloses the following relationships:
Cortechs.ai, icometrix, Subtle Medical, Darmiyan

Accreditation

Radiologic Technologists:
This course meets all criteria and has been approved by the AHRA, The Association for Medical Imaging Management for One (1) ARRT Category A CE Credit.

Radiology Administrators:
This course meets all CRA renewal credit criteria and has been approved for One (1) continuing education credit in the following CRA domains: Asset Resource Management (AM) and Operations Management (OM).

For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board or other credentialing organization.

Method of Participation/Criteria for Success

CE Credits
To receive CE credits for participating in this CE activity you must successfully complete the online post examination with a passing score of 80% or higher.

Online examinations return an immediate grade report. Upon receiving a passing score click Continue and complete the evaluation form. To view and print your Statement of Credit click the Print/View Certificate button displayed from within your MyAR Archives page.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.